Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Campbell McInnes
Observed names:
C. MCINNES,
C. McInnes,
Campbell Mcinnes
Institution:
University of South Carolina
Observed institutions:
University of Alberta,
University of South Carolina,
Cyclacel Pharmaceuticals (United Kingdom),
Institute of Structural and Molecular Biology,
University of Edinburgh
OpenAlex ID:
A5110026436
2-Anilino-4-(thiazol-5-yl)pyrimidine CDK Inhibitors: Synthesis, SAR Analysis, X-ray Crystallography, and Biological Activity
2004
·
Shudong Wang
, Christopher Meades
, et al.
·
Journal of Medicinal Chemistry
·
153
Structure of Free MDM2 N-terminal Domain Reveals Conformational Adjustments that Accompany p53-binding
2005
·
Stanislava Uhrinova
, Dusan Uhrin
, et al.
·
Journal of Molecular Biology
·
141
Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design
2005
·
George Kontopidis
, Su-Ying Wu
, et al.
·
Proceedings of the National Academy of Sciences
·
126
Discovery of a Novel Family of CDK Inhibitors with the Program LIDAEUS
2003
·
Su Ying Wu
, Iain McNae
, et al.
·
Structure
·
108
PDF
Development of the Structural Basis for Antimicrobial and Hemolytic Activities of Peptides Based on Gramicidin S and Design of Novel Analogs Using NMR Spectroscopy
2000
·
Campbell McInnes
, Leslie H. Kondejewski
, et al.
·
Journal of Biological Chemistry
·
69
Insights into Cyclin Groove Recognition
2003
·
George Kontopidis
, Martin J.I. Andrews
, et al.
·
Structure
·
61
PDF
Highly potent p21WAF1‐derived peptide inhibitors of CDK‐mediated pRb phosphorylation: Delineation and structural insight into their interactions with cyclin A
2002
·
D.I. Zheleva
, C. McInnes
, et al.
·
Journal of Peptide Research
·
60
Design, synthesis, biological activity and structural analysis of cyclic peptide inhibitors targeting the substrate recruitment site of cyclin-dependent kinase complexes
2004
·
Martin J. I. Andrews
, Campbell McInnes
, et al.
·
Organic & Biomolecular Chemistry
·
57
Design of a versatile linker for solid phase peptide synthesis: Synthesis of C-terminal primary/seconary amides and hydrazides
1993
·
R. Ramage
, S.L. Irving
, et al.
·
Tetrahedron Letters
·
54
Design, Synthesis, and Evaluation of 2-Methyl- and 2-Amino-N-aryl-4,5-dihydrothiazolo[4,5-h]quinazolin-8-amines as Ring-Constrained 2-Anilino-4-(thiazol-5-yl)pyrimidine Cyclin-Dependent Kinase Inhibitors
2010
·
Neil A. McIntyre
, Campbell McInnes
, et al.
·
Journal of Medicinal Chemistry
·
35
Peptide inhibitors of CDK2-cyclin A that target the cyclin recruitment-Site: structural variants of the C-Terminal Phe
2002
·
Gail E Atkinson
, Angela Cowan
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
18
Improved lead-finding for kinase targets using high-throughput docking.
2006
·
Campbell McInnes
·
PubMed
·
9
Conformational differences between cis and trans proline isomers of a peptide antigen representing the receptor binding domain of Pseudomonas aeruginosa as studied by 1H‐nmr
1994
·
Campbell Mcinnes
, Cyril M. Kay
, et al.
·
Biopolymers
·
8
Structure-based discovery and optimization of potential cancer therapeutics targeting the cell cycle.
2006
·
Mark P Thomas
, Campbell McInnes
·
PubMed
·
7
Abstract 5018: PROTAC degraders of CDK8/CDK19 Mediator kinases potently suppress multiple myeloma proliferation
2023
·
Li Zhang
, Jing Li
, et al.
·
Cancer Research
·
1
Modulation of specificity in cyclic antimicrobial peptides by amphipathicity
2006
·
Leslie H. Kondejewski
, Campbell McInnes
, et al.
·
Kluwer Academic Publishers eBooks
·
1
Structural and biochemical studies of human PCNA complexes provide the basis for association with CDK/cyclin and a rationale for inhibitor design
2004
·
G. Kontopidis
, S.-Y. Wu
, et al.
·
Acta Crystallographica Section A Foundations of Crystallography
·
1
Therapeutic Degradation of Protein Kinases Through PROTACs: Current Status and Future Potential
2020
·
Li Zhang
, Campbell McInnes
·
Medicinal chemistry reviews
Abstract LB-198: Design and synthesis of non-ATP competitive inhibitors of CDK4/Cyclin D using REPLACE
2011
·
Shu Liu
, Padmavathy Nandha Premnath
, et al.
·
Cancer Research
Cambridge Healthtech Institute fourth annual conference in structure-based drug design.
2004
·
Campbell McInnes
·
PubMed
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(2,4-Dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-N',N'-dimethyl-benzene-1,4-diamine
2003
·
S. Wang
, C. Meades
, et al.
·
Worldwide Protein Data Bank
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-[4-(4-Methyl-2-methylamino-thiazol-5-yl)-pyrimidin-2-ylamino]-phenol
2003
·
S. Wang
, C. Meades
, et al.
·
Worldwide Protein Data Bank
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2-Amino-4-methyl-thiazol-5-yl)-pyrimidin-2-yl]-(3-nitro-phenyl)-amine
2003
·
S. Wang
, C. Meades
, et al.
·
Worldwide Protein Data Bank
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,4-Dimethyl-thiazol-5-yl)-pyrimidin-2-ylamine
2003
·
S.Y. Wu
, I. McNae
, et al.
·
Worldwide Protein Data Bank
ChemInform Abstract: Design of a Versatile Linker for Solid Phase Peptide Synthesis: Synthesis of C‐Terminal Primary/Seconary Amides and Hydrazides.
1994
·
R. RAMAGE
, S. L. IRVING
, et al.
·
ChemInform
Show more works
View as search
Works count:
27
Citation count:
909
H-index:
11
I10-index:
11
Year
Topic
Type